A total of 18 vouchers have been issued via the framework despite a lack of clarity on the awarding process.
OPKO Health is refocusing on drug development, with most pipeline assets in early stages and limited near-term catalysts.
Draft guidance, issued by the FDA last week, could remove ambiguity and uncertainty that may have so far limited uptake of ...
Accelerated approval of semaglutide 7.2 mg establishes a higher-dose, once-weekly GLP-1 RA option for long-term weight ...
Legal marijuana use doesn’t always protect job candidates. Learn how state and local laws shape THC testing, hiring decisions ...
The FDA’s Commissioner’s National Priority Voucher program, unveiled in June 2025, is “shrouded in secrecy,” Democratic ...
Achieve exceeded long-term safety study requirements and secured a manufacturing partnership, positioning for a potential 1H ...
Submitted GraftAssureDx™ for kidney transplant rejection testing for FDA review on Wednesday, March 25Welcomed second ...
Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...
Food safety experts weigh in.
A panel of physicians, biotech leaders and patient advocates took aim at the FDA during a Senate hearing Thursday on how the agency’s bureaucracy affects innovation, with one witness testifying that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results